Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a

American Journal of Gastroenterology

Volumn 97, Issue 11, 2002, Pages 2880-2885

  Hofer, Harald ^a   Bankl, Hans C ^a   Wrba, Friedrich ^a   Steindl Munda, Petra ^a   Peck Radosavljevic, Markus ^a   Österreicher, Christoph ^a   Mueller, Christian ^a   Gangl, Alfred ^a   Ferenci, Peter ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHOLESTEROL; INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC HEPATITIS; FATTY LIVER; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS HEPATITIS; VIRUS REPLICATION; VIRUS TYPING;

EID: 0036840043     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2002.07056.x     Document Type: Article

References (30)

1. Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358-64.
2. Serfaty L, Andreani T, Giral P, et al. Hepatitis C virus induced hypobetalipoproteinemia: A possible mechanism for steatosis in chronic hepatitis C. J Hepatol 2001;34:428-34.
3. Moriya K, Todoroki T, Tsutsumi T, et al. Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: Analysis in transgenic mice and humans. Biochem Biophys Res Comm 2001;281:1207-12.
4. Moriya K, Yotsuyanagi H, Shintani Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997;78:1527-31.
5. Moriya K, Fujie H, Shintani Y, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-7.
6. Barba G, Harper F, Harada T, et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 1997;94:1200-5.
7. Thomssen R, Bonk S, Thile A. Density heterogeneities of hepatitis C virus in human sera due to binding of beta-lipoproteins and immunogloulins. Med Microbiol Immunol 1993;182:329-34.
8. Baiocchi L, Tisone G, Palmieri G, et al. Hepatic steatosis: A specific sign of hepatitis C reinfection after liver transplantation. Liver Transpl Surg 1998;4:441-7.
9. Czaja AJ, Carpenter HA, Santrach PJ, et al. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998;29:198-206.
10. Mihm S, Fayyazi A, Hartmann H, et al. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 1997;25:735-9.
11. Rubbia-Brandt H, Quadri R, Abid K, et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 2000;33:106-15.
12. Adinolfi LE, Utili R, Andreana A, et al. Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients. Eur J Gastroenterol Hepatol 2000;12:299-304.
13. Scheuer PJ, Ashrafzadeh P, Sherlock S, et al. The pathology of hepatitis C. Hepatology 1992;15:567-71.
14. Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis 1995;15:70-81.
15. Badizadegan K, Jonas M, Ott MJ, et al. A histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998;28:1416-23.
16. Lefkowitch JH, Schiff ER, Davis GL, et al. Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993;104:595-603.
17. Schwarz KB, Larroya S, Vogler C, et al. Role of Influenza B virus in hepatic steatosis and mitochondrial abnormalities in a mouse model of Reye syndrome. Hepatology 1991;13:96-103.
18. Haque S, Chandra B, Gerber M, et al. Iron overload in patients with chronic hepatitis C: A clinicopathologic study. Hum Pathol 1996;27:1277-81.
19. Kaserer K, Fiedler R, Steindl P, et al. Liver biopsy is a useful predictor of response to interferon-therapy in chronic hepatitis C. Histopathology 1998;32:454-61.
20. Ferenci P, Brunner H, Nachbaur K, et al. Combination of interferon induction therapy and ribavirin in chronic hepatitis C. Hepatology 2001;34:1006-11.
21. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alpha-2a plus ribavirin for chronic hepatitis C virus infection. NEJM 2002;347:975-82.
22. Ludwig J. The nomenclature of chronic active hepatitis: An obituary. Gastroenterology. 1993;105:274-8.
23. Kazemi-Shirazi L, Datz CH, Maier-Dobersberger TH, et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999;116:127-34.
24. Hourigan LF, MacDonald GA, Purdie D, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999;29:1215-9.
25. Teli MR, Day CP, Burt AD, et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995;346:987-90.
26. Bacon BR, Farahvash MJ, Janney CG, et al. Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 1994;107:1103-9.
27. George DK, Goldwurm S, Macdonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114:311-8.
28. Mendler MH, Turlin B, Moirand R, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999;117:1155-63.
29. Soardo G, Pirisi M, Fonda M, et al. Changes in blood lipid composition and response to interferon treatment in chronic hepatitis C. J Interferon Cytokine Res 1995;15:705-12.
30. Maggi G, Botteli R, Gola D, et al. Serum cholesterol and chronic hepatitis C. Ital J Gastroenterol 1996;28:436-40.